Tradestie Institutional Equity Comparison Engine

CVM vs MGTX โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

MGTX Overall Edge

MGTX Captures Institutional Edge (3โ€“1 Pillars ยท 8โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to MeiraGTx Holdings plc Ordinary Shares (MGTX) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while CVM counters with relative strength in Valuation. Fundamentally, CVM trades at 23.0x Forward P/E with 0.0% operating margin (-62.7% YoY revenue) versus MGTX at 64.1x Forward P/E and 46.3% operating margin (+8608.6% YoY). In options structure, CVM sits in BREAKDOWN (N/A IV; Dealer Gamma Walls on Pro) against MGTX sits in BREAKDOWN (3rd %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner CVM
CVM 23.0x vs MGTX 64.1x Fwd P/E
Growth & Margin Winner MGTX
Op Margin 0.0% vs 46.3% ยท YoY -62.7% vs +8608.6%
Momentum & Technical Winner MGTX
1Y -77.5% vs +7.1% ยท 52W Pos 10% vs 26%
Options & Structure Winner MGTX
BREAKDOWN (N/A IV) vs BREAKDOWN (3rd %ile IV)
CVM NYSE American
Cel-Sci Corporation
Biological Products, (No Disgnostic Substances)
$1.59
+24.22% 1D
Market Cap $20.9M
1M Return -11.17%
1Y Return -77.48%
Forward P/E 23.0x
Unified AI Score
56.6 / 100 HOLD
Tech 60.0 Fund 54.0 Flow 50.0 Mom 60.0
MGTX NASDAQ
MeiraGTx Holdings plc Ordinary Shares
Biological Products, (No Disgnostic Substances)
$8.85
-3.59% 1D
Market Cap $844.2M
1M Return -4.63%
1Y Return +7.14%
Forward P/E 64.1x
Unified AI Score
48.0 / 100 HOLD
Tech 48.0 Fund 57.0 Flow 70.0 Mom 58.9

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: CVM -77.48% MGTX +7.14% Spread: +84.04 pp (MGTX Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period CVM Revenue MGTX Revenue CVM Op. Margin MGTX Op. Margin Margin Edge
FY2014 $0M N/A -9721.4% N/A CVM
FY2019 N/A $10M N/A -438.4% MGTX
FY2020 N/A $20M N/A -401.9% MGTX
FY2021 N/A $40M N/A -193.0% MGTX
FY2022 N/A $20M N/A -730.9% MGTX
FY2023 N/A $10M N/A -977.8% MGTX
FY2024 N/A $30M N/A -493.4% MGTX
FY2025 N/A $80M N/A -130.2% MGTX

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: CVM (2) vs MGTX (8)
Institutional Metric CVM MGTX Criterion Row Winner
Market Capitalization Scale $20.9M $844.2M Larger Scale MGTX
Trailing P/E Ratio Valuation 23.0x 10.1x Lower Multiple MGTX
Forward P/E Ratio Valuation 23.0x 64.1x Lower Multiple CVM
Revenue Growth (YoY) Growth -62.7% +8608.6% Higher Growth MGTX
Operating Margin (TTM) Profitability 0.0% 46.3% Higher Margin MGTX
Net Profit Margin Profitability 0.0% 19.9% Higher Margin MGTX
Return on Equity (ROE) Capital Efficiency -252.5% 72.2% Higher ROE MGTX
52-Week Range Position Momentum 10% ($1โ€“$8) 26% ($7โ€“$15) Stronger Trend MGTX
Beta / 30D Volatility Risk Regime 0.65ฮฒ ยท 120% Vol 1.65ฮฒ ยท 68% Vol Lower Realized Risk MGTX
Unified Institutional Score Composite Signal 56.6 / 100 (HOLD) 48.0 / 100 (HOLD) Higher Composite CVM

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full CVM vs MGTX Buy Guide
CVM BREAKDOWN
29d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live CVM Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
MGTX BREAKDOWN
62d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 3rd %ile
IV Regime Compressed (<25th %ile)
Live MGTX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither CVM nor MGTX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.